1. Home
  2. PKX vs BBIO Comparison

PKX vs BBIO Comparison

Compare PKX & BBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo POSCO Holdings Inc.

PKX

POSCO Holdings Inc.

N/A

Current Price

$59.68

Market Cap

18.0B

Sector

Industrials

ML Signal

N/A

Logo BridgeBio Pharma Inc.

BBIO

BridgeBio Pharma Inc.

N/A

Current Price

$73.95

Market Cap

15.3B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PKX
BBIO
Founded
1968
2015
Country
South Korea
United States
Employees
N/A
N/A
Industry
Steel/Iron Ore
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
18.0B
15.3B
IPO Year
1998
2019

Fundamental Metrics

Financial Performance
Metric
PKX
BBIO
Price
$59.68
$73.95
Analyst Decision
Strong Buy
Analyst Count
0
23
Target Price
N/A
$82.26
AVG Volume (30 Days)
158.1K
2.8M
Earning Date
01-01-0001
05-22-2026
Dividend Yield
2.35%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$502,076,000.00
Revenue This Year
$5.89
$88.86
Revenue Next Year
$3.90
$74.11
P/E Ratio
$42.95
N/A
Revenue Growth
N/A
126.26
52 Week Low
$40.80
$28.33
52 Week High
$71.35
$84.94

Technical Indicators

Market Signals
Indicator
PKX
BBIO
Relative Strength Index (RSI) 39.80 58.38
Support Level $58.83 $70.65
Resistance Level $61.24 $79.56
Average True Range (ATR) 1.90 3.35
MACD -1.34 0.42
Stochastic Oscillator 15.49 86.03

Price Performance

Historical Comparison
PKX
BBIO

About PKX POSCO Holdings Inc.

POSCO Holdings Inc is a holding company and operates through its subsidiaries. The company operates across four distinct segments. The first segment is the Steel Segment, which includes the production and sale of steel products. The second segment is the Infrastructure Business, which is further divided into three operations. The Trading Segment comprises trading and natural resource development activities. The Construction Segment involves the planning, designing, and construction of industrial plants, civil engineering projects, and buildings. The Logistics and Others Segment. The third segment is the Secondary Battery Materials Segment, and the fourth segment is the Others Segment.

About BBIO BridgeBio Pharma Inc.

BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis), is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.

Share on Social Networks: